(Hypertension. 1999;33:1338-1341.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Clinical Pharmacology Unit, Department of Medicine, University of Cambridge Clinical School, Cambridge, UK (K.M.O., B.F., F.F., I.L., S.D.); and the Department of Obstetrics and Gynaecology, Chelsea and Westminster Hospital and Central Middlesex Hospital Trust, London, UK (N.H.M.).
Correspondence to Dr Kevin M. O'Shaughnessy, Clinical Pharmacology Unit, Level 6, ACCI, Box 110, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. E-mail kmo22{at}medschl.cam.ac.uk
AbstractPreeclampsia is a heritable condition that develops as a result of widespread vascular endothelial dysfunction. The thrombotic tendency in this condition has suggested a number of candidate genes, and there have been recent reports of positive association with the Leiden variant of factor V and the thermolabile variant of methylenetetrahydrofolate reductase. We attempted to reproduce these results in a large cohort of well-characterized women with preeclampsia, recruited prospectively within the East Anglian region of the United Kingdom. Women in the preeclampsia cohort (n=283) were genotyped for both the Leiden variant (G1691A) of factor V and the thermolabile variant (C677T) of methylenetetrahydrofolate reductase. Genotype and allele frequencies were compared with those of 2 control groups, one consisting of women recruited prospectively (n=100) from the same maternity hospital as the subjects and another consisting of normotensive women (n=100) from East Anglia. No significant differences were detected. Specifically, the carrier rate for the Leiden variant was 5.3% in the preeclampsia group and 5.5% in the combined control group. T677 homozygotes for methylenetetrahydrofolate reductase were 11% and 11.5% in the 2 groups, respectively. We conclude that there is no evidence of association of preeclampsia with either of these 2 polymorphisms in our study population.
Key Words: preeclampsia thrombosis polymorphisms factor V methylenetetrahydrofolate reductase association study
This article has been cited by other articles:
![]() |
M. Tanaka, G. Jaamaa, M. Kaiser, E. Hills, A. Soim, M. Zhu, I. Y. Shcherbatykh, R. Samelson, E. Bell, M. Zdeb, et al. Racial Disparity in Hypertensive Disorders of Pregnancy in New York State: A 10-Year Longitudinal Population-Based Study Am J Public Health, January 1, 2007; 97(1): 163 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Carmel, R. Green, D. S. Rosenblatt, and D. Watkins Update on Cobalamin, Folate, and Homocysteine Hematology, January 1, 2003; 2003(1): 62 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M O'Shaughnessy, B. Fu, S. Downing, and N. H Morris Thrombophilic polymorphisms in pre-eclampsia: altered frequency of the functional 98C>T polymorphism of glycoprotein IIIa J. Med. Genet., November 1, 2001; 38(11): 775 - 777. [Full Text] [PDF] |
||||
![]() |
J. K. Lynch, K. B. Nelson, C. J. Curry, and J. K. Grether Cerebrovascular Disorders in Children With the Factor V Leiden Mutation J Child Neurol, October 1, 2001; 16(10): 735 - 744. [Abstract] [PDF] |
||||
![]() |
M. S. Esplin, M. B. Fausett, A. Fraser, R. Kerber, G. Mineau, J. Carrillo, and M. W. Varner Paternal and Maternal Components of the Predisposition to Preeclampsia N. Engl. J. Med., March 22, 2001; 344(12): 867 - 872. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |